<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02444897</url>
  </required_header>
  <id_info>
    <org_study_id>2012-12-514</org_study_id>
    <nct_id>NCT02444897</nct_id>
  </id_info>
  <brief_title>The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy</brief_title>
  <official_title>The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Keimyung University Dongsan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to assess the effectiveness of epidural patient-controlled analgesia
      compared to intravenous patient-controlled analgesia in patients undergoing laparoscopic
      gastrectomy. The investigators hypothesized that epidural PCA would be more effective in pain
      control than IV PCA even for laparoscopic gastrectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS score</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>pain degree was checked at every 24hours for 5days after operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of participants with complication</measure>
    <time_frame>for 5days after operation</time_frame>
    <description>PCA related complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel motility</measure>
    <time_frame>for 5days after operation</time_frame>
    <description>by counting Colomark on abdomen x-ray</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Epidural PCA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural patient-controlled analgesia group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV PCA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous patient-controlled analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural PCA Ropivacaine</intervention_name>
    <description>Epidural catheter insertion at T10 level before surgery, the tip of catheter location at T8-9 level.
Total volume: 500ml, 16.7mcg/kg+0.75% Ropivacaine 80ml+N/S</description>
    <arm_group_label>Epidural PCA group</arm_group_label>
    <other_name>Epidural patient-controlled analgesia Ropivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV PCA Fentanyl+nefopam+Ramosetron</intervention_name>
    <description>Total volume: 84ml, Fentanyl 1000mcg+nefopam 120mg+Ramosetron 0.3mg Basal infusion: 1ml/hr, Bolus: 0.5ml with a lockout time 15min.</description>
    <arm_group_label>IV PCA group</arm_group_label>
    <other_name>intravenous patient-controlled analgesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed adenocarcinoma in stomach

          -  Males or Females, aged≥19 years and ≤80 years

          -  Scheduled as laparoscopic gastrectomy

          -  Patient has given their written informed consent to participate in the study

        Exclusion Criteria:

          -  History of hypersensitivity for analgesics

          -  Recent history of narcotic analgesics

          -  Disability of central nerve system

          -  Uncontrolled co-morbidity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung Wan Ryu, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director of gastrointestinal surgery devision, associate proffessor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2015</study_first_posted>
  <last_update_submitted>May 14, 2015</last_update_submitted>
  <last_update_submitted_qc>May 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Keimyung University Dongsan Medical Center</investigator_affiliation>
    <investigator_full_name>Seung Wan Ryu</investigator_full_name>
    <investigator_title>Director of Gastrointesinal surgery, associate professor</investigator_title>
  </responsible_party>
  <keyword>Gastric cancer</keyword>
  <keyword>epidural</keyword>
  <keyword>PCA</keyword>
  <keyword>laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Nefopam</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Ramosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

